A detailed history of Rfg Advisory, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Rfg Advisory, LLC holds 16,763 shares of JNJ stock, worth $2.55 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
16,763
Previous 16,072 4.3%
Holding current value
$2.55 Million
Previous $2.6 Million 6.91%
% of portfolio
0.07%
Previous 0.08%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$143.34 - $165.86 $99,047 - $114,609
691 Added 4.3%
16,763 $2.42 Million
Q3 2024

Oct 16, 2024

SELL
$145.48 - $167.38 $352,352 - $405,394
-2,422 Reduced 13.1%
16,072 $2.6 Million
Q2 2024

Jul 15, 2024

BUY
$144.38 - $157.78 $192,891 - $210,794
1,336 Added 7.79%
18,494 $2.7 Million
Q1 2024

Apr 11, 2024

SELL
$155.22 - $162.74 $204,269 - $214,165
-1,316 Reduced 7.12%
17,158 $2.71 Million
Q4 2023

Jan 25, 2024

SELL
$145.6 - $158.88 $41,350 - $45,121
-284 Reduced 1.51%
18,474 $2.9 Million
Q3 2023

Oct 16, 2023

BUY
$155.75 - $174.48 $327,386 - $366,756
2,102 Added 12.62%
18,758 $2.92 Million
Q2 2023

Aug 03, 2023

SELL
$154.35 - $166.11 $1.31 Million - $1.41 Million
-8,467 Reduced 33.7%
16,656 $2.76 Million
Q1 2023

May 09, 2023

BUY
$151.05 - $180.26 $360,254 - $429,920
2,385 Added 10.49%
25,123 $3.89 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $48,700 - $54,656
304 Added 1.36%
22,738 $4.02 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $95,830 - $106,634
594 Added 2.72%
22,434 $3.9 Million
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $232,270 - $256,879
-1,381 Reduced 5.95%
21,840 $3.74 Million
Q1 2022

May 11, 2022

SELL
$158.14 - $179.59 $34,632 - $39,330
-219 Reduced 0.93%
23,221 $4.12 Million
Q4 2021

Feb 02, 2022

BUY
$155.93 - $173.01 $566,805 - $628,891
3,635 Added 18.35%
23,440 $4.01 Million
Q3 2021

Oct 19, 2021

BUY
$161.5 - $179.47 $18,088 - $20,100
112 Added 0.57%
19,805 $3.2 Million
Q2 2021

Jul 29, 2021

BUY
$159.48 - $171.07 $637 - $684
4 Added 0.02%
19,693 $3.24 Million
Q1 2021

Apr 19, 2021

SELL
$153.07 - $170.48 $11,786 - $13,126
-77 Reduced 0.39%
19,689 $3.24 Million
Q4 2020

Feb 02, 2021

BUY
$137.11 - $157.38 $43,600 - $50,046
318 Added 1.64%
19,766 $3.16 Million
Q3 2020

Oct 13, 2020

BUY
$140.38 - $153.83 $125,920 - $137,985
897 Added 4.84%
19,448 $2.9 Million
Q2 2020

Aug 03, 2020

BUY
$128.81 - $155.51 $76,255 - $92,061
592 Added 3.3%
18,551 $2.61 Million
Q1 2020

Apr 17, 2020

SELL
$111.14 - $153.99 $5,112 - $7,083
-46 Reduced 0.26%
17,959 $2.36 Million
Q4 2019

Jan 22, 2020

BUY
$127.5 - $146.44 $137,062 - $157,423
1,075 Added 6.35%
18,005 $2.63 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $263,167 - $294,656
2,073 Added 13.95%
16,930 $2.19 Million
Q2 2019

Aug 23, 2019

BUY
$131.15 - $144.24 $1.58 Million - $1.74 Million
12,054 Added 430.04%
14,857 $2.07 Million
Q2 2019

Aug 15, 2019

SELL
$131.15 - $144.24 $1.4 Million - $1.54 Million
-10,692 Reduced 79.23%
2,803 $390,000
Q1 2019

Apr 25, 2019

SELL
$125.72 - $139.79 $89,261 - $99,250
-710 Reduced 5.0%
13,495 $1.89 Million
Q4 2018

Feb 15, 2019

SELL
$122.84 - $147.84 $122,225 - $147,100
-995 Reduced 6.55%
14,205 $1.83 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $357,566 - $420,210
2,941 Added 23.99%
15,200 $2.1 Million
Q2 2018

Jul 25, 2018

BUY
$119.4 - $131.76 $162,503 - $179,325
1,361 Added 12.49%
12,259 $1.49 Million
Q1 2018

May 10, 2018

BUY
$125.1 - $148.14 $62,550 - $74,070
500 Added 4.81%
10,898 $1.4 Million
Q4 2017

Feb 08, 2018

SELL
$131.22 - $143.62 $4,067 - $4,452
-31 Reduced 0.3%
10,398 $1.47 Million
Q3 2017

Nov 02, 2017

SELL
$129.47 - $135.38 $52,823 - $55,235
-408 Reduced 3.76%
10,429 $1.39 Million
Q2 2017

Nov 01, 2017

SELL
N/A
-396 Reduced 3.53%
10,837 $1.43 Million
Q2 2017

Aug 14, 2017

BUY
N/A
121 Added 1.09%
11,233 $1.48 Million
Q1 2017

Nov 01, 2017

BUY
N/A
2,388 Added 27.37%
11,112 $1.39 Million
Q4 2016

Nov 01, 2017

BUY
N/A
8,724
8,724 $1.04 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $398B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Rfg Advisory, LLC Portfolio

Follow Rfg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.